THE TRUTH ABOUT: 15 - Caught on Camera

From Crisis to Possible Cure Path: San Antonio Battles Highest Diabetes Rates as Wegovy and Medicare (United States) Expansion Offer New Hope

Diabetes care is entering a new era in San Antonio as the Wegovy pill and expanded Medicare coverage offer new hope for preventing and managing diabetes in one of America's hardest-hit cities.

Medical Daily · Jun 4

Why insulin, the core element of diabetes treatment remains inaccessible for millions of people

The discovery of insulin in 1921 revolutionised diabetes care. Type 1 diabetes went from being a death sentence to a manageable chronic condition.

The Conversation · Jun 4

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

GLASGOW, Scotland, June 4, 2026 /PRNewswire/ -- New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), equivalent to around eight additional days in full…

AAP · Jun 3

The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to know

​ Fish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diabetic rats, suggesting inflammation plays a key role even without excess weight. Omega-3 fatty acids shifted immune cells towards an anti-inflammatory state, potentially improving metabolic health.

The Economic Times · Jun 1

Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soon

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabetes, heart disease, and infections. This move aims to reduce treatment costs for millions of patients managing chronic illnesses, with benefits expected to reach consumers within two to three months as new…

The Economic Times · Jun 1

Medicare Drug Savings Surge: 1 in 3 Seniors Now Pays Less Than $35 a Month for Insulin—Here’s How

Nationwide, an estimated 3.5 to 4 million older adults (seniors aged 65 and older) rely on insulin to manage their diabetes. Somewhere around one in...

Saving Advice · May 31

MannKind Wins FDA Approval for Afrezza in Children, Opening Pediatric Diabetes Market

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ages 6 and older, expanding the inhaled mealtime insulin’s label into children and adolescents. Chief Executive Officer Michael Castagna called the decision “a truly historic

MarketBeat · May 31

India’s GLP-1 Weight Loss Drug Problem Nobody Is Warning You About

A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs…

MyLifeXP · May 29

Could GLP-1 Drugs Do More Than Aid Weight Loss? Some Studies Link Them to Lower Tumor Risk

GLP-1 medications already changed the conversation around weight loss, diabetes care, and metabolic health. Now researchers explore an even more intriguing question: could these drugs influence cancer risk as well. Early studies continue to spark interest because they show patterns that go beyond appetite control and blood sugar regulation.

Clever Dude · May 28

Don’t Ignore This: Why Professional Primary Care Services Are Essential for Better Health

Many health conditions begin quietly without obvious symptoms. People often assume they are healthy simply because they do not feel sick, but hidden issues such as high blood pressure, diabetes, and heart disease can slowly develop over time.

inkl · May 28